Rupp M, Walter N, Pfeifer C, Lang S, Kerschbaum M, Krutsch W, Baumann F, Alt V. The incidence of fractures among the adult population of Germany—an analysis from 2009 through 2019. Dtsch Arztebl Int. 2021;118:665–9. https://doi.org/10.3238/arztebl.m2021.0238.
Article PubMed PubMed Central Google Scholar
Tajeu GS, Delzell E, Smith W, et al. Death, debility, and destitution following hip fracture. J Gerontol A Biol Sci Med Sci. 2014;69A(3):346–53.
Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int. 1997;7(5):407–13. https://doi.org/10.1007/pl00004148.
Article CAS PubMed Google Scholar
Naranjo A, Fernández-Conde S, Ojeda S, Torres-Hernández L, Hernández-Carballo C, Bernardos I, Rodríguez S, Laynez P. Preventing future fractures: effectiveness of an orthogeriatric fracture liaison service compared to an outpatient fracture liaison service and the standard management in patients with hip fracture. Arch Osteoporos. 2017;12(1):112. https://doi.org/10.1007/s11657-017-0373-9.
Budair B, Ahmed U, Hodson J, et al. Are we all guilty of under-estimating intra-operative blood loss during hip fracture surgery? J Orthop. 2017;14:81–4. https://doi.org/10.1016/j.jor.2016.10.019.
Cui H, Chen K, Lv S, et al. An analysis of perioperative hidden blood loss in femoral intertrochanteric fractures: bone density is an important influencing factor. BMC Musculoskelet Disord. 2021;22:6. https://doi.org/10.1186/s12891-020-03922-x.
Article CAS PubMed PubMed Central Google Scholar
Fenwick A, Pfann M, Mayr J, Antonovska I, Wiedl A, Feldmann M, Nuber S, Förch S, Mayr E. Anticoagulants and fracture morphology have a significant influence on total blood loss after proximal femur fractures. Eur J Trauma Emerg Surg. 2023;49(1):173–9. https://doi.org/10.1007/s00068-022-02090-y.
Cai L, Wang T, Di L, Hu W, Wang J. Comparison of intramedullary and extramedullary fixation of stable intertrochanteric fractures in the elderly: a prospective randomised controlled trial exploring hidden perioperative blood loss. BMC Musculoskelet Disord. 2016;17:475. https://doi.org/10.1186/s12891-016-1333-z.
Article CAS PubMed PubMed Central Google Scholar
Smith GH, Tsang J, Molyneux SG, White TO. The hidden blood loss after hip fracture. Injury. 2011;42(2):133–5. https://doi.org/10.1016/j.injury.2010.02.015.
Article CAS PubMed Google Scholar
Foss NB, Kristensen MT, Kehlet H. Anaemia impedes functional mobility after hip fracture surgery. Age Ageing. 2008;37(2):p173-178.
Halm EA, Wang JJ, Boockvar K, et al. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma. 2004;18(6):369–74.
Article PubMed PubMed Central Google Scholar
Ashkenazi I, Schermann H, Gold A, Lin R, Pardo I, Steinberg E, Sternheim A, Snir N. Tranexamic acid in hip hemiarthroplasty. Injury. 2020;51(11):2658–62. https://doi.org/10.1016/j.injury.2020.07.061.
Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, Hudson JI, Provenzano G. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion. 1999;39(7):694–700. https://doi.org/10.1046/j.1537-2995.1999.39070694.x.
Article CAS PubMed Google Scholar
Arshi A, Lai WC, Iglesias BC, McPherson EJ, Zeegen EN, Stavrakis AI, Sassoon AA. Blood transfusion rates and predictors following geriatric hip fracture surgery. Hip Int. 2021;31(2):272–9. https://doi.org/10.1177/1120700019897878.
Kim JL, Park JH, Han SB, Cho IY, Jang KM. Allogeneic blood transfusion is a significant risk factor for surgical-site infection following total hip and knee arthroplasty: a meta-analysis. J Arthroplasty. 2017;32(1):320–5. https://doi.org/10.1016/j.arth.2016.08.026.
Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (Roy Coll Path). 1980;14:41–7.
CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid o death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized, placebo-controlled trial. Lancet. 2010;376:23–32.
Lei J, Zhang B, et al. Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial. J Orthop Surg Res. 2017;12:124. https://doi.org/10.1186/s13018-017-0625-9.
Article PubMed PubMed Central Google Scholar
Zhang J, Fan X, Zheng Y, Wu J, Yuan X. Intravenous application of tranexamic acid in intramedullary nailing for the treatment of geriatric intertrochanteric fractures: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2023;24(1):614. https://doi.org/10.1186/s12891-023-06725-y.
Article PubMed PubMed Central Google Scholar
Khatib Y, Bal G, Liu R, Ashaia W, Sorial R. A randomised controlled trial assessing the effect of tranexamic acid on post-operative blood transfusions in patient with intra-capsular hip fractures treated with hemi- or total hip arthroplasty. Arch Orthop Trauma Surg. 2024;144(7):3095–102. https://doi.org/10.1007/s00402-024-05325-2.
Geddes J, McConaghie G. Does perioperative use of tranexamic acid in hip fracture patients increase the risk of venous thromboembolism and reduce the need for postoperative transfusions? J Perioper Pract. 2020;30(12):378–82.
Xi J, Hu Q, et al. Efficacy and safety of tranexamic acid in geriatric hip fracture with hemiarthroplasty: a retrospective cohort study. BMC Musculoskelet Disord. 2019;20:304. https://doi.org/10.1186/s12891-019-2670-5.
Gill R, Ganatra B, Althabe F. WHO essential medicines for reproductive health. BMJ Glob Health. 2019;4(6): e002150. https://doi.org/10.1136/bmjgh-2019-002150.
Article PubMed PubMed Central Google Scholar
Fenwick A, Antonovska I, Pfann M, Mayr J, Wiedl A, Nuber S, Förch S, Mayr E. Does tranexamic acid reliably reduce blood loss in proximal femur fracture surgery? Eur J Trauma Emerg Surg. 2023;49(1):209–16. https://doi.org/10.1007/s00068-022-02042-6.
Article CAS PubMed Google Scholar
Zhang P, Liang Y, et al. Combined application versus topical and intravenous application of tranexamic acid following primary total hip arthroplasty: a meta-analysis. BMC Musculoskelet Disord. 2017;18:90. https://doi.org/10.1186/s12891-017-1429-0.
Article CAS PubMed PubMed Central Google Scholar
Doka R, Neibaur S, Mohammad S, Small R, Dirkx M, Yaish A, Brannan GD. Evaluation of the early administration of tranexamic acid in geriatric hip fractures in the emergency department: a retrospective study. Cureus. 2024;16(6): e62636. https://doi.org/10.7759/cureus.62636.
Article PubMed PubMed Central Google Scholar
Wang C, Kang P, Ma J, Yue C, Xie J, Pei F. Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: a double-blind, randomized controlled trial of different doses. Thromb Res. 2016;141:119–23. https://doi.org/10.1016/j.thromres.2016.02.027.
Article CAS PubMed Google Scholar
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Article CAS PubMed Google Scholar
ASA Physical Classification System. American Society of Anesthesiologists. http://www.asahq.org/Home/For-Members/Clincal-Information/ASA-Physical-Status-Classification-System/
Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin. 1996;13(8):465–78. https://doi.org/10.1185/03007999609115227.
留言 (0)